Standard

Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia. / Jeene, Paul M.; Kuijper, Steven C.; van den Boorn, Héctor G. et al.

In: Acta Oncologica, Vol. 61, No. 7, 2022, p. 849-855.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

APA

Vancouver

Author

BibTeX

@article{ebe3ba498bd140d79f04fb245d972501,
title = "Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia",
abstract = "Introduction: The recent POLDER trial investigated the effects of external beam radiotherapy (EBRT) on dysphagia caused by incurable oesophageal cancer. An estimated life expectancy of minimally three months was required for inclusion. However, nearly one-third of the included patients died within three months. The aim of this study was to investigate if the use of prediction models could have improved the physician{\textquoteright}s estimation of the patient{\textquoteright}s survival. Methods: Data from the POLDER trial (N = 110) were linked to the Netherlands Cancer Registry to retrieve patient, tumour, and treatment characteristics. Two published prediction models (the SOURCE model and Steyerberg model) were used to predict three-month survival for all patients included in the POLDER trial. Predicted survival probabilities were dichotomised and the accuracy, sensitivity, specificity, and the area under the curve (AUC) were used to evaluate the predictive performance. Results: The SOURCE and Steyerberg model had an accuracy of 79% and 64%, and an AUC of 0.76 and 0.60 (p =.017), respectively. The SOURCE model had higher specificity across survival cut-off probabilities, the Steyerberg model had a higher sensitivity beyond the survival probability cut-off of 0.7. Using optimal cut-off probabilities, SOURCE would have wrongfully included 16/110 patients into the POLDER and Steyerberg 34/110. Conclusion: The SOURCE model was found to be a more useful decision aid than the Steyerberg model. Results showed that the SOURCE model could be used for three-month survival predictions for patients that are considered for palliative treatment of dysphagia caused by oesophageal cancer in addition to clinicians{\textquoteright} judgement.",
keywords = "Prediction models, decision aid, external beam radiotherapy, oesophageal cancer",
author = "Jeene, {Paul M.} and Kuijper, {Steven C.} and {van den Boorn}, {H{\'e}ctor G.} and {el Sharouni}, {Sherif Y.} and Braam, {P. tra M.} and Vera Oppedijk and Verhoeven, {Rob H. A.} and Hulshof, {Maarten C. C. M.} and {van Laarhoven}, {Hanneke W. M.}",
note = "Funding Information: This work was supported by The Dutch Cancer Society, grant number UVA 2014-7000. The authors thank the registration team of the Netherlands Comprehensive Cancer Organisation (IKNL) for the collection of data for the Netherlands Cancer Registry. Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",
year = "2022",
doi = "10.1080/0284186X.2022.2079385",
language = "English",
volume = "61",
pages = "849--855",
journal = "Acta oncologica (Stockholm, Sweden)",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "7",

}

RIS

TY - JOUR

T1 - Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagia

AU - Jeene, Paul M.

AU - Kuijper, Steven C.

AU - van den Boorn, Héctor G.

AU - el Sharouni, Sherif Y.

AU - Braam, P. tra M.

AU - Oppedijk, Vera

AU - Verhoeven, Rob H. A.

AU - Hulshof, Maarten C. C. M.

AU - van Laarhoven, Hanneke W. M.

N1 - Funding Information: This work was supported by The Dutch Cancer Society, grant number UVA 2014-7000. The authors thank the registration team of the Netherlands Comprehensive Cancer Organisation (IKNL) for the collection of data for the Netherlands Cancer Registry. Publisher Copyright: © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

PY - 2022

Y1 - 2022

N2 - Introduction: The recent POLDER trial investigated the effects of external beam radiotherapy (EBRT) on dysphagia caused by incurable oesophageal cancer. An estimated life expectancy of minimally three months was required for inclusion. However, nearly one-third of the included patients died within three months. The aim of this study was to investigate if the use of prediction models could have improved the physician’s estimation of the patient’s survival. Methods: Data from the POLDER trial (N = 110) were linked to the Netherlands Cancer Registry to retrieve patient, tumour, and treatment characteristics. Two published prediction models (the SOURCE model and Steyerberg model) were used to predict three-month survival for all patients included in the POLDER trial. Predicted survival probabilities were dichotomised and the accuracy, sensitivity, specificity, and the area under the curve (AUC) were used to evaluate the predictive performance. Results: The SOURCE and Steyerberg model had an accuracy of 79% and 64%, and an AUC of 0.76 and 0.60 (p =.017), respectively. The SOURCE model had higher specificity across survival cut-off probabilities, the Steyerberg model had a higher sensitivity beyond the survival probability cut-off of 0.7. Using optimal cut-off probabilities, SOURCE would have wrongfully included 16/110 patients into the POLDER and Steyerberg 34/110. Conclusion: The SOURCE model was found to be a more useful decision aid than the Steyerberg model. Results showed that the SOURCE model could be used for three-month survival predictions for patients that are considered for palliative treatment of dysphagia caused by oesophageal cancer in addition to clinicians’ judgement.

AB - Introduction: The recent POLDER trial investigated the effects of external beam radiotherapy (EBRT) on dysphagia caused by incurable oesophageal cancer. An estimated life expectancy of minimally three months was required for inclusion. However, nearly one-third of the included patients died within three months. The aim of this study was to investigate if the use of prediction models could have improved the physician’s estimation of the patient’s survival. Methods: Data from the POLDER trial (N = 110) were linked to the Netherlands Cancer Registry to retrieve patient, tumour, and treatment characteristics. Two published prediction models (the SOURCE model and Steyerberg model) were used to predict three-month survival for all patients included in the POLDER trial. Predicted survival probabilities were dichotomised and the accuracy, sensitivity, specificity, and the area under the curve (AUC) were used to evaluate the predictive performance. Results: The SOURCE and Steyerberg model had an accuracy of 79% and 64%, and an AUC of 0.76 and 0.60 (p =.017), respectively. The SOURCE model had higher specificity across survival cut-off probabilities, the Steyerberg model had a higher sensitivity beyond the survival probability cut-off of 0.7. Using optimal cut-off probabilities, SOURCE would have wrongfully included 16/110 patients into the POLDER and Steyerberg 34/110. Conclusion: The SOURCE model was found to be a more useful decision aid than the Steyerberg model. Results showed that the SOURCE model could be used for three-month survival predictions for patients that are considered for palliative treatment of dysphagia caused by oesophageal cancer in addition to clinicians’ judgement.

KW - Prediction models

KW - decision aid

KW - external beam radiotherapy

KW - oesophageal cancer

UR - http://www.scopus.com/inward/record.url?scp=85131433175&partnerID=8YFLogxK

U2 - 10.1080/0284186X.2022.2079385

DO - 10.1080/0284186X.2022.2079385

M3 - Article

C2 - 35651320

VL - 61

SP - 849

EP - 855

JO - Acta oncologica (Stockholm, Sweden)

JF - Acta oncologica (Stockholm, Sweden)

SN - 0284-186X

IS - 7

ER -

ID: 24871245